The influence of circadian rhythms on the kinetics of drugs in humans.
about
Chronopharmacology of anti-convulsive therapyDoes the clock make the poison? Circadian variation in response to pesticidesAntiresorptive effect of a cathepsin K inhibitor ONO-5334 and its relationship to BMD increase in a phase II trial for postmenopausal osteoporosis.Circadian rhythms in gene expression: Relationship to physiology, disease, drug disposition and drug action.Diurnal variation in CYP1A2 enzyme activity in South Asians and Europeans.Chronotypes in Patients with Epilepsy: Does the Type of Epilepsy Make a Difference?Toxicological aspects of the use of phenolic compounds in disease prevention.Circadian variation in tamoxifen pharmacokinetics in mice and breast cancer patients.Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp.Pharmacological Targeting the REV-ERBs in Sleep/Wake RegulationMorning vs evening dosing of the cathepsin K inhibitor ONO-5334: effects on bone resorption in postmenopausal women in a randomized, phase 1 trialChronotherapy: Intuitive, Sound, Founded…But Not Broadly Applied.Lights, rhythms, infection: the role of light and the circadian clock in determining the outcome of plant-pathogen interactions.State of the art in therapeutic drug monitoring.Molecular mechanisms of the circadian clockwork in mammals.Chronopharmacokinetics of drugs in toxicological aspects: A short review for pharmacy practitioners.Efficacy and safety of chronomodulated chemotherapy for patients with metastatic colorectal cancer: a systematic review and meta-analysis.Circadian rhythms of liver physiology and disease: experimental and clinical evidence.Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine.Intestinal expression of mouse Abcg2/breast cancer resistance protein (BCRP) gene is under control of circadian clock-activating transcription factor-4 pathway.Orexin receptor antagonism: an ascending multiple-dose study with almorexant.Identifying 24 h variation in the pharmacokinetics of levofloxacin: a population pharmacokinetic approach.Nephron-Specific Deletion of Circadian Clock Gene Bmal1 Alters the Plasma and Renal Metabolome and Impairs Drug DispositionCircadian expression profiles of drug-processing genes and transcription factors in mouse liver.Population Pharmacokinetic Model Characterizing 24-Hour Variation in the Pharmacokinetics of Oral and Intravenous Midazolam in Healthy Volunteers.Circadian study of decompression sickness symptoms and response-associated variables in rats.Designing simple PK-PD studies in children.A randomized study comparing short-time infusion of oxaliplatin in combination with capecitabine XELOX(30) and chronomodulated XELOX(30) as first-line therapy in patients with advanced colorectal cancer.Perspectives on the relevance of the circadian time structure to workplace threshold limit values and employee biological monitoring.Circadian hormone control in a human-on-a-chip: In vitro biology's ignored component?Evaluation of the effect of time dependent dosing on pharmacokinetic and pharmacodynamics of amlodipine in normotensive and hypertensive human subjects.Circadian Mechanisms In Alcohol Use Disorder and Tissue Injury.Dissociation between the pharmacokinetics and pharmacodynamics of once-daily rivaroxaban and twice-daily apixaban: a randomized crossover study.Chronopharmacokinetics of Erlotinib and Circadian Rhythms of Related Metabolic Enzymes in Lewis Tumor-Bearing Mice.The effect of circadian rhythm on pharmacokinetics and metabolism of the Cdk inhibitor, roscovitine, in tumor mice model.Increased risk of gastrointestinal acute GVHD following the addition of melphalan to busulfan/cyclophosphamide conditioning
P2860
Q28396131-387D46DE-9CEE-4091-91EF-B3A1C1C4BFF4Q28475862-EDF4FF65-74D4-4493-B617-FCC6D0C98FFFQ33814283-2754D9F1-D862-4A8F-B6DA-9085384045C4Q34069298-BB50B298-FFEE-4A89-9614-A1B8006691C5Q34320302-1E0F2379-820B-4477-AAD3-9B33B1029624Q35675815-A439FBDD-D8F6-464C-8BC8-92ECE10C25FDQ35743072-E981A508-33F2-46BC-BEEA-11E898CB6C01Q35747766-E7BA27F4-B4E6-4D94-92AF-033C066277D1Q35852614-CEB2A9C4-5EC2-4789-9198-B02761966C00Q36125453-088D0038-69B9-4295-B80A-1ED8366654A5Q36471074-345550DC-343E-4026-93A6-66A27E566018Q37371203-2FFD03D3-807D-49B4-925D-20E4DB9D16D7Q37605433-011F8D95-6C51-4164-819B-D062BC1868D4Q37699413-5B36EC22-4A11-4C9F-8AD7-D658D789F51AQ38218726-51A9E2C5-4DF0-4C2D-AEFE-75B67C51F7F1Q38225885-CCDACD7D-AFF1-487E-AE02-D5A5294D70ECQ38739748-5BF6C6DF-D042-41E9-A3D7-B87B72B257AEQ38747400-2EA4CECA-D634-4468-B980-F80A602A924AQ38959281-202773FF-EE84-4A0A-A225-E284016C99F3Q39384079-FE378618-38F9-4306-BD65-C891A7FDA436Q39603334-0315DB85-A3F9-4A72-BAE3-C2D8AB7716A1Q40225657-D3A60F65-8854-4B36-B997-A76969F9EBE7Q41645452-EAA9B880-65F0-4A2E-8A82-5A575BDEEF57Q43125380-FD2D5BA3-7047-4C96-9E71-E913F403710EQ43127353-AE063379-DF95-40B3-BC93-ECB08C009821Q43141776-634D6067-2034-4E4C-B5D2-DC8398399338Q45401802-003CB83D-1162-43AB-9066-31B749852DB0Q45923777-80CC6702-FCA0-42E0-9AB8-FFBB332912FDQ47272851-6476D3A0-1CBA-440C-AD7A-84DF9A2046BBQ47414437-F80C736C-E13C-421E-BC47-EFB6DE8D5433Q48769966-CED81C38-4D7C-451C-8915-C57408235CA2Q49946039-69C1300C-F892-403C-888E-91B459FA4A48Q50504217-4BFA7EBE-92D5-49BF-9C30-F10E1E01E25FQ51003977-6F172281-AF8B-4BB8-A7DC-328D07E52553Q55059946-239BFEDE-85FA-4B9B-A983-01F0D155A6BBQ58788918-62ABB663-E922-47A9-B050-4B4785641C0B
P2860
The influence of circadian rhythms on the kinetics of drugs in humans.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The influence of circadian rhythms on the kinetics of drugs in humans.
@en
The influence of circadian rhythms on the kinetics of drugs in humans.
@nl
type
label
The influence of circadian rhythms on the kinetics of drugs in humans.
@en
The influence of circadian rhythms on the kinetics of drugs in humans.
@nl
prefLabel
The influence of circadian rhythms on the kinetics of drugs in humans.
@en
The influence of circadian rhythms on the kinetics of drugs in humans.
@nl
P2860
P356
P1476
The influence of circadian rhythms on the kinetics of drugs in humans.
@en
P2093
Massimo Baraldo
P2860
P304
P356
10.1517/17425255.4.2.175
P407
P577
2008-02-01T00:00:00Z